OTC · IMUN
Immune Therapeutics, Inc.
Healthcare · Biotechnology
$0.09
Down-$0.01 (-7.00%)
Updated Aug 16, 2026, 3:35 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.78M
- P/E ratio
- -0.58
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.83K
- Avg. volume
- 13.81K
Price performance
IMUN price history
1M range · 0 trading sessions · Daily adjusted prices
IMUN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest IMUN news
The latest Smart Investors Daily articles mentioning IMUN.
Stock researchCompany · Overview
IMUN research
Overview
Company profile and research snapshot.
Company profile
Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
